| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| A Kinase Anchor Proteins | 10 | 2026 | 21 | 4.330 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 11 | 2026 | 158 | 2.420 |
Why?
|
| Cell Cycle Proteins | 6 | 2024 | 677 | 1.890 |
Why?
|
| Myocardium | 18 | 2020 | 847 | 1.850 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2026 | 20 | 1.820 |
Why?
|
| Myocardial Contraction | 10 | 2026 | 239 | 1.600 |
Why?
|
| Excitation Contraction Coupling | 2 | 2026 | 14 | 1.110 |
Why?
|
| Cyclic AMP | 4 | 2020 | 222 | 0.890 |
Why?
|
| Receptors, Adrenergic | 1 | 2024 | 18 | 0.850 |
Why?
|
| Calcium | 14 | 2024 | 1031 | 0.810 |
Why?
|
| Protein Transport | 2 | 2022 | 349 | 0.780 |
Why?
|
| Heart Failure | 5 | 2026 | 2289 | 0.770 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 609 | 0.760 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2022 | 78 | 0.730 |
Why?
|
| Signal Transduction | 8 | 2019 | 4472 | 0.730 |
Why?
|
| Cardiomegaly | 4 | 2016 | 119 | 0.720 |
Why?
|
| Diet, High-Fat | 2 | 2019 | 239 | 0.680 |
Why?
|
| Second Messenger Systems | 1 | 2020 | 11 | 0.670 |
Why?
|
| Drug Discovery | 1 | 2022 | 172 | 0.660 |
Why?
|
| Ventricular Function | 2 | 2020 | 86 | 0.650 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2026 | 45 | 0.650 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 24 | 0.640 |
Why?
|
| Disease Models, Animal | 9 | 2019 | 4429 | 0.640 |
Why?
|
| Cardiovascular Diseases | 2 | 2026 | 2036 | 0.630 |
Why?
|
| Heart Diseases | 1 | 2024 | 490 | 0.610 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 181 | 0.550 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 144 | 0.550 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 12 | 0.550 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 189 | 0.540 |
Why?
|
| Pericardium | 1 | 2018 | 103 | 0.530 |
Why?
|
| Aortic Diseases | 1 | 2019 | 186 | 0.530 |
Why?
|
| Mechanical Phenomena | 1 | 2017 | 14 | 0.530 |
Why?
|
| Intracellular Space | 1 | 2017 | 46 | 0.520 |
Why?
|
| Troponin I | 3 | 2008 | 119 | 0.520 |
Why?
|
| Calcinosis | 1 | 2018 | 184 | 0.510 |
Why?
|
| Heart | 5 | 2016 | 650 | 0.490 |
Why?
|
| Aorta | 1 | 2019 | 518 | 0.480 |
Why?
|
| Lipids | 1 | 2019 | 550 | 0.480 |
Why?
|
| Animals | 32 | 2026 | 33051 | 0.480 |
Why?
|
| Cardiomyopathies | 3 | 2018 | 500 | 0.470 |
Why?
|
| Atherosclerosis | 2 | 2019 | 929 | 0.440 |
Why?
|
| Heart Function Tests | 2 | 2016 | 51 | 0.440 |
Why?
|
| Phosphorylation | 8 | 2019 | 1536 | 0.440 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1569 | 0.430 |
Why?
|
| Isoproterenol | 4 | 2024 | 89 | 0.420 |
Why?
|
| HEK293 Cells | 4 | 2022 | 767 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2746 | 0.350 |
Why?
|
| Mice | 20 | 2024 | 17596 | 0.320 |
Why?
|
| Muscular Atrophy | 2 | 2021 | 74 | 0.320 |
Why?
|
| Stem Cells | 3 | 2020 | 683 | 0.320 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2019 | 226 | 0.310 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2008 | 1 | 0.300 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 980 | 0.280 |
Why?
|
| Carrier Proteins | 6 | 2015 | 1011 | 0.260 |
Why?
|
| Mutation | 6 | 2017 | 5941 | 0.230 |
Why?
|
| Cell Differentiation | 5 | 2019 | 1842 | 0.230 |
Why?
|
| Peptides | 1 | 2008 | 829 | 0.220 |
Why?
|
| Binding Sites | 2 | 2018 | 1185 | 0.200 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2001 | 154 | 0.190 |
Why?
|
| Virus Internalization | 1 | 2022 | 54 | 0.180 |
Why?
|
| Luciferases | 1 | 2022 | 125 | 0.180 |
Why?
|
| Nanotechnology | 1 | 2022 | 48 | 0.180 |
Why?
|
| Protein Binding | 2 | 2018 | 1661 | 0.180 |
Why?
|
| Rats | 7 | 2011 | 3390 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2024 | 824 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 173 | 0.180 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 113 | 0.170 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 2304 | 0.170 |
Why?
|
| Electrocardiography | 3 | 2018 | 967 | 0.170 |
Why?
|
| Calcium-Binding Proteins | 4 | 2018 | 327 | 0.170 |
Why?
|
| Humans | 18 | 2026 | 126754 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 177 | 0.170 |
Why?
|
| Sarcomeres | 4 | 2013 | 32 | 0.170 |
Why?
|
| Adipocytes | 1 | 2022 | 167 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 307 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2020 | 57 | 0.160 |
Why?
|
| Mice, Knockout | 5 | 2022 | 3709 | 0.160 |
Why?
|
| Myosin Heavy Chains | 4 | 2002 | 74 | 0.160 |
Why?
|
| Mice, SCID | 2 | 2018 | 568 | 0.160 |
Why?
|
| Male | 16 | 2024 | 62543 | 0.160 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2011 | 124 | 0.160 |
Why?
|
| Myoblasts | 1 | 2019 | 31 | 0.160 |
Why?
|
| Biological Clocks | 1 | 2019 | 28 | 0.160 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 7 | 0.160 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2019 | 32 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 291 | 0.160 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2017 | 146 | 0.160 |
Why?
|
| Neointima | 1 | 2019 | 45 | 0.150 |
Why?
|
| Actin Cytoskeleton | 2 | 2004 | 48 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2019 | 111 | 0.150 |
Why?
|
| Sequestosome-1 Protein | 1 | 2018 | 15 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 136 | 0.150 |
Why?
|
| Cardiotonic Agents | 2 | 2011 | 135 | 0.150 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2018 | 42 | 0.150 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 412 | 0.140 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 291 | 0.140 |
Why?
|
| Heart Ventricles | 8 | 2015 | 761 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 316 | 0.140 |
Why?
|
| Echocardiography | 4 | 2018 | 1114 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 192 | 0.130 |
Why?
|
| Cytosol | 2 | 2017 | 138 | 0.130 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 78 | 0.130 |
Why?
|
| Mice, Mutant Strains | 4 | 2013 | 365 | 0.130 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 972 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 277 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 4504 | 0.130 |
Why?
|
| Sarcolemma | 1 | 2016 | 13 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 254 | 0.120 |
Why?
|
| Histone Chaperones | 1 | 2016 | 9 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 21 | 0.120 |
Why?
|
| Autophagy | 1 | 2018 | 404 | 0.120 |
Why?
|
| Acetylcysteine | 1 | 2016 | 79 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2021 | 872 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 230 | 0.110 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 67 | 0.100 |
Why?
|
| Cricetulus | 1 | 2013 | 87 | 0.100 |
Why?
|
| CHO Cells | 1 | 2013 | 148 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2013 | 280 | 0.100 |
Why?
|
| Cricetinae | 1 | 2013 | 365 | 0.100 |
Why?
|
| Phenotype | 3 | 2018 | 4304 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 132 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 1126 | 0.090 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 1 | 2011 | 3 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 398 | 0.090 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2011 | 20 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 1765 | 0.090 |
Why?
|
| Propanolamines | 1 | 2011 | 18 | 0.090 |
Why?
|
| Milrinone | 1 | 2011 | 30 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2013 | 767 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2019 | 2337 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2019 | 2397 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2893 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 101 | 0.080 |
Why?
|
| Hypertension | 1 | 1997 | 1301 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 664 | 0.070 |
Why?
|
| Electric Stimulation | 3 | 1998 | 243 | 0.070 |
Why?
|
| Rats, Inbred WKY | 2 | 1998 | 38 | 0.070 |
Why?
|
| Rats, Inbred SHR | 2 | 1998 | 48 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 283 | 0.070 |
Why?
|
| Acute Disease | 1 | 2011 | 1135 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1162 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 457 | 0.060 |
Why?
|
| Transcriptome | 3 | 2019 | 1052 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2008 | 239 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2537 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2008 | 515 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2008 | 573 | 0.060 |
Why?
|
| Gene Expression | 1 | 2008 | 1482 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2001 | 235 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3066 | 0.050 |
Why?
|
| Ventricular Myosins | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2002 | 4 | 0.050 |
Why?
|
| Diltiazem | 1 | 2002 | 14 | 0.050 |
Why?
|
| Acylation | 1 | 2022 | 16 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2022 | 52 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 109 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 28 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 1 | 2001 | 46 | 0.040 |
Why?
|
| Propofol | 1 | 2001 | 48 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2001 | 43 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2001 | 252 | 0.040 |
Why?
|
| Family Health | 1 | 2001 | 248 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 59 | 0.040 |
Why?
|
| Female | 3 | 2024 | 68330 | 0.040 |
Why?
|
| Transgenes | 1 | 2001 | 330 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2002 | 891 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2001 | 230 | 0.040 |
Why?
|
| Connexins | 1 | 2019 | 55 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 62 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 18 | 0.040 |
Why?
|
| Actins | 1 | 2001 | 311 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 412 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 404 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 563 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2018 | 60 | 0.040 |
Why?
|
| Actomyosin | 1 | 1998 | 5 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 255 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1997 | 5 | 0.030 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1997 | 5 | 0.030 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 13 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1997 | 20 | 0.030 |
Why?
|
| Prazosin | 1 | 1997 | 16 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 359 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 1997 | 14 | 0.030 |
Why?
|
| Colforsin | 1 | 1997 | 45 | 0.030 |
Why?
|
| Oxazoles | 1 | 1997 | 20 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2001 | 476 | 0.030 |
Why?
|
| Phosphates | 1 | 1998 | 108 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 523 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1997 | 153 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 288 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 186 | 0.030 |
Why?
|
| Apoptosis | 2 | 2016 | 1811 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 111 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 11 | 0.030 |
Why?
|
| Receptors, Purinergic | 1 | 1996 | 14 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 36 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 420 | 0.030 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2016 | 34 | 0.030 |
Why?
|
| Renal Agents | 1 | 2016 | 3 | 0.030 |
Why?
|
| Alleles | 1 | 2001 | 1609 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 87 | 0.030 |
Why?
|
| Mesoderm | 1 | 2016 | 104 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 849 | 0.030 |
Why?
|
| Aurora Kinases | 1 | 2015 | 26 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 2757 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 396 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 216 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 334 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 321 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2018 | 525 | 0.030 |
Why?
|
| Heart Rate | 2 | 2011 | 572 | 0.030 |
Why?
|
| Indoles | 1 | 2015 | 199 | 0.030 |
Why?
|
| Dependovirus | 1 | 2015 | 144 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1994 | 30 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 257 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 999 | 0.030 |
Why?
|
| Myofibrils | 2 | 2004 | 24 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 658 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 498 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 549 | 0.020 |
Why?
|
| Fetus | 1 | 2016 | 578 | 0.020 |
Why?
|
| Receptors, Opioid, delta | 1 | 2011 | 12 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2015 | 501 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 1015 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 502 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 822 | 0.020 |
Why?
|
| Neutrophils | 1 | 1994 | 349 | 0.020 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2011 | 8 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2004 | 307 | 0.020 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2011 | 14 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 756 | 0.020 |
Why?
|
| Propranolol | 1 | 2011 | 111 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 120 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2011 | 85 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1184 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2016 | 1047 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6134 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2101 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1370 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 214 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 536 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2883 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2591 | 0.020 |
Why?
|
| Homozygote | 2 | 2001 | 540 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 2 | 1999 | 36 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2011 | 756 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1874 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1312 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 3222 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 2004 | 18 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2004 | 101 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1996 | 266 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1999 | 2310 | 0.010 |
Why?
|
| Connexin 43 | 1 | 2003 | 27 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 20 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 32 | 0.010 |
Why?
|
| Calcineurin | 1 | 2003 | 59 | 0.010 |
Why?
|
| Calsequestrin | 1 | 2002 | 12 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 20344 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2002 | 49 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2001 | 23 | 0.010 |
Why?
|
| Myosins | 1 | 2001 | 41 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 10555 | 0.010 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 66 | 0.010 |
Why?
|
| Minoxidil | 1 | 2000 | 4 | 0.010 |
Why?
|
| Calcineurin Inhibitors | 1 | 2000 | 20 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2001 | 156 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 27697 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2000 | 99 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2000 | 126 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12546 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 510 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 690 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 85 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 602 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 1495 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1996 | 21 | 0.010 |
Why?
|
| Oscillometry | 1 | 1996 | 15 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1996 | 21 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1996 | 55 | 0.010 |
Why?
|
| Action Potentials | 1 | 1999 | 463 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 841 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 147 | 0.010 |
Why?
|
| Heart Atria | 1 | 1999 | 326 | 0.010 |
Why?
|
| Caffeine | 1 | 1996 | 65 | 0.010 |
Why?
|
| Bucladesine | 1 | 1994 | 18 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 14 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 19 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1994 | 16 | 0.010 |
Why?
|
| Fluorides | 1 | 1994 | 16 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 59 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1994 | 29 | 0.010 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1994 | 22 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1994 | 54 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 260 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 1595 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 985 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 1090 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1994 | 1014 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 3262 | 0.010 |
Why?
|
| Cell Line | 1 | 1994 | 2560 | 0.000 |
Why?
|